Back to top
more

Tandem Diabetes Care (TNDM)

(Real Time Quote from BATS)

$45.83 USD

45.83
499,826

+1.53 (3.45%)

Updated Aug 27, 2024 03:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tandem Diabetes (TNDM) Q3 Earnings Preview: What's Shaping Up?

by Zacks Equity Research

Tandem Diabetes (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tandem Diabetes (TNDM) Q3 Earnings Preview: What to Look Out For

by Zacks Equity Research

Tandem Diabetes (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Buy Tandem Diabetes (TNDM) Stock Now

by Zacks Equity Research

Strength in domestic sales along with the recent launch of the t:slim X2 Insulin Pump in select international markets bode well for Tandem Diabetes (TNDM).

Implied Volatility Surging for Tandem Diabetes Care (TNDM) Stock Options

by Zacks Equity Research

Tandem Diabetes Care (TNDM) needs investors to pay close attention to the stock based on moves in the options market lately.

    Sreyoshi Mukherjee headshot

    US Diabetes Market Gaining Momentum: 3 Stocks in Focus

    by Sreyoshi Mukherjee

    A rising geriatric population and lifestyle disorders are expanding the U.S. diabetic population.

      Is Tandem Diabetes Care (TNDM) Stock Outpacing Its Medical Peers This Year?

      by Zacks Equity Research

      Is (TNDM) Outperforming Other Medical Stocks This Year?

        Tandem Diabetes Care (TNDM) Catches Eye: Stock Jumps 7.4%

        by Zacks Equity Research

        Tandem Diabetes Care (TNDM) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

          Options Traders Expect Huge Moves in Tandem Diabetes Care (TNDM) Stock

          by Zacks Equity Research

          Tandem Diabetes Care (TNDM) needs investors to pay close attention to the stock based on moves in the options market lately.

            5 Health Care ETFs Outperforming XLV on YTD Basis

            by Zacks Equity Research

            Health care ETFs provide handsome returns year to date.

              Is the Options Market Predicting a Spike in Tandem Diabetes (TNDM) Stock?

              by Zacks Equity Research

              Investors need to pay close attention Tandem Diabetes (TNDM) stock based on the movements in the options market lately.

                Company News For Jun 25, 2018

                by Zacks Equity Research

                Companies In The News are: RHT,BB,KMX,TNDM

                  Options Traders Expect Huge Moves in Tandem Diabetes Care (TNDM) Stock

                  by Zacks Equity Research

                  Investors in Tandem Diabetes Care (TNDM) need to pay close attention to the stock based on moves in the options market lately.

                    Tandem Diabetes Care (TNDM): Moving Average Crossover Alert

                    by Zacks Equity Research

                    Tandem Diabetes Care, Inc. (TNDM) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front

                      The Zacks Analyst Blog Highlights: Tandem Diabetes Care, Addus HomeCare, Tailored Brands, Tellurian and Johnson & Johnson

                      by Zacks Equity Research

                      The Zacks Analyst Blog Highlights: Tandem Diabetes Care, Addus HomeCare, Tailored Brands, Tellurian and Johnson & Johnson

                        Tirthankar Chakraborty headshot

                        Wall Street Brushes Off Trade War Fears: Top 5 Gainers

                        by Tirthankar Chakraborty

                        The Dow climbed more than 700 points after investors downplayed fears over tariffs announced by both China and the United States.

                          Tandem Diabetes Care (TNDM) Shares March Higher, Can It Continue?

                          by Zacks Equity Research

                          As of late, it has definitely been a great time to be an investor in Tandem Diabetes Care, Inc. (TNDM)

                            New Year to Bring Back MedTech Tax, 3 Stocks Unfazed

                            by Zacks Equity Research

                            Investors are apprehensive about the re-enactment of MedTech Tax and related concerns, despite raking in returns from other sectors.

                              The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT

                              by Zacks Equity Research

                              The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT

                                5 MedTech Stocks for Stellar Returns in Q3

                                by Zacks Equity Research

                                Here we take a sneak peek into two burning issues that are likely to impact the quarterly numbers in the MedTech fraternity.

                                  4 Top Growth Picks as MedTech Battle Rages On

                                  by Zacks Equity Research

                                  Trump's Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.

                                    The Saga to Revoke Obamacare Continues: 3 MedTech Picks

                                    by Zacks Equity Research

                                    In the wake of the turbulent political scenario and banking on favorable metrics, these three MedTech stocks stand out as the most suitable picks.

                                      Implied Volatility Surging for Tandem (TNDM) Stock Options

                                      by Zacks Equity Research

                                      Tandem (TNDM) warrants investors' attention based on moves in the options market lately.

                                        3 Med-Instrument Stocks Poised to Gain this Earnings Season

                                        by Zacks Equity Research

                                        2015 is forecasted to be a transition year for the medical instruments sector.